You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

GSK Supply Status

Please note: this page is updated weekly. If a product is not listed below, GSK are not experiencing supply constraints. Please contact your wholesaler

Product name

PIP Code

Status

Estimated recovery date

ADARTREL TAB 0.25MG 1X12_GB 3106432 OUT OF STOCK EARLY MAY 2025
EUMOVATE CRM 0.05% 100G UK-GSK 483503 OUT OF STOCK EARLY MAY 2025
EUMOVATE OINT 0.05% 100G UK-GSK 29827 OUT OF STOCK EARLY MAY 2025
FLIXONASE ANS 50MCG 1X150D_GB 2656106 OUT OF STOCK LATE MAY 2025
IMIGRAN N.S. 10MGX2 CP GB 2946960 OUT OF STOCK LATE MAY 2025
IMIGRAN N.S. 20MGX2 CP UK 2390219 OUT OF STOCK EARLY JUNE 2025
IMIGRAN N.S. 20X6 CP UK 2330728 OUT OF STOCK LATE MAY 2025
REQUIP TAB 0.25MG 1X21_GB 3940277 OUT OF STOCK LATE MAY 2025
ZYBAN TAB 150MG 6X10_GB 2709848 OUT OF STOCK LATE APRIL 2025
LATE NOVEMBER 2021BACTROBAN NASAL OINT 2% TUBE 3GX1 UK-GSK
LAMICTAL CD TABLET 2MG 1X30

Product name

PIP Code

Status

Estimated recovery date

If you have any queries about the availability of a product, please contact your wholesaler.

3rd Party Distribution

From 1st Sept 2023, GSK and Recordati have agreed a deal whereby RECORDATI PHARMACEUTICALS LIMITED will take over the Distribution and Commercial activities for the following products.

Product name

PIP Code

AVODART Capsules 0.5mg x 30 2921070
COMBODART Capsules 0.5mg/0.4mg x 30 3542560
LATE NOVEMBER 2021BACTROBAN NASAL OINT 2% TUBE 3GX1 UK-GSK
LAMICTAL CD TABLET 2MG 1X30

Orders can be placed at this email address: 

commercialdeptorders@clarity-pharma.com

Further information

If you require further information, please contact our UK Customer Contact Centre (customercontactuk@gsk.com).

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GSK on 0800 221 441 or UKSafety@gsk.com